Shine Drugs Private Limited - Company Profile

It is a trading private limited company based in Medak, Telangana, India, established in 2021.
2021 Medak, Telangana, India Active
Last Updated:
Access Report
About Shine Drugs Private Limited

Shine Drugs Private Limited, a active private limited company, was established on 10 May 2021 in Medak, Telangana, India. Engaging in specialty within the trading sector, it holds CIN: U51909TG2021PTC151274. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.

Its leadership includes Srungarapu Jyothi (Director), Muttangi Sriman (Director), Vijaya Harsha Kumar Geddam (Director). Past directors included Pavani Pothula. It is based at Sy No 228/9, Plot No 44/B, Kucharam Kucharam Industrial Park, Manoharabad, Medak, Telangana, 502336.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U51909TG2021PTC151274

  • Registration Number

    151274

  • Incorporation Date

    10 May 2021

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 4 Year, 9 Months
Company report

Shine Drugs Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Shine Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Shine Drugs Private Limited?
Current Directors
Name Designation Appointment Date Status
Srungarapu Jyothi Director 10 May 2021 Current
Muttangi Sriman Director 10 May 2021 Current
Vijaya Harsha Kumar Geddam Director 10 May 2021 Current
Ankita Jain Director 10 May 2021 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 06 Jan 2022 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Shine Drugs.

Enhance accessibility to Shine Drugs's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Shine Drugs revenue growth over time
Shine Drugs profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Shine Drugs?

Unlock access to Shine Drugs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Shine Drugs?

Shine Drugs has a workforce of 0 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Shine Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shine Drugs's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Shine Drugs
Recent Activity within the Organization
  • Director Appointment

    Progress on Srungarapu Jyothi was appointed as a Director was appointed as a Director on 10 May 2021 & has been associated with this company since 4 years 9 months . was documented.

  • Director Appointment

    The activity Muttangi Sriman was appointed as a Director was appointed as a Director on 10 May 2021 & has been associated with this company since 4 years 9 months . was completed.

  • Director Appointment

    The activity Vijaya Harsha Kumar Geddam was appointed as a Director was appointed as a Director on 10 May 2021 & has been associated with this company since 4 years 9 months . was completed.

  • Director Appointment

    The activity Ankita Jain was appointed as a Director was appointed as a Director on 10 May 2021 & has been associated with this company since 4 years 9 months . was completed.

  • Company Incorporation

    Shine Drugs Private Limited was registered on 10 May 2021 with Roc Hyderabad & aged 4 years 9 months as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Shine Drugs Private Limited?

The CIN of Shine Drugs Private Limited is U51909TG2021PTC151274.

Where is Shine Drugs Private Limited headquartered?

Shine Drugs Private Limited is headquartered at Sy No 228/9, Plot No 44/B, Kucharam Kucharam Industrial Park, Manoharabad, Medak, Telangana, 502336.

When was Shine Drugs Private Limited incorporated?

Shine Drugs Private Limited was incorporated on 10 May 2021.

Who are the current directors of Shine Drugs Private Limited?

The current directors of Shine Drugs Private Limited are

What is the primary industry of Shine Drugs Private Limited?

The primary industry of Shine Drugs Private Limited is Trading.

Is Shine Drugs Private Limited a listed company?

Shine Drugs Private Limited is unlisted.

What is the capital structure of Shine Drugs Private Limited?

The authorized capital of Shine Drugs Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available